OPEN END TURBO BULL OPTIONSSCHEIN - AMGEN | Market Closed - BOERSE MUENCHEN 15:40:54 2024-06-25 EDT | ||
| 8.84 EUR | +3.39% |
|
| Current month | +18.50% | ||
| 1 month | +15.56% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 24-06-25 | 8.84 | +3.39% |
| 24-06-24 | 8.55 | +6.61% |
| 24-06-21 | 8.02 | +1.01% |
| 24-06-20 | 7.94 | +4.20% |
| 24-06-19 | 7.62 | +0.53% |
Real-time BOERSE MUENCHEN
Last update June 25, 2024 at 03:40 pm
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | 
UniCredit
|
| WKN | HC4MLX |
| ISIN | DE000HC4MLX4 |
| Date issued | 2023-02-28 |
| Strike | 225.2 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 2.85 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 10.07 € |
|---|---|
| Lowest since issue | 0.6 € |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
319.3
USD
Average target price
316.4
USD
Spread / Average Target
-0.90%
- Stock Market
- Certificates
- Certificat
